The Discounted Cash Flow (DCF) valuation of Qingdao Haier Biomedical Co Ltd (688139.SS) is 19.10 CNY. With the latest stock price at 33.20 CNY, the upside of Qingdao Haier Biomedical Co Ltd based on DCF is -42.5%.
Based on the latest price of 33.20 CNY and our DCF valuation, Qingdao Haier Biomedical Co Ltd (688139.SS) is a sell. selling 688139.SS stocks now will result in a potential gain of 42.5%.
| Range | Selected | |
| WACC / Discount Rate | 9.2% - 12.6% | 10.9% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | 14.52 - 28.44 | 19.10 |
| Upside | -56.3% - -14.3% | -42.5% |